Vanda Pharmaceuticals, Inc. (VNDA)

5.85 -0.25 (-4.10%) USD  |  NASDAQ  |  Feb 20, 15:20
More

Vanda Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
AbbVie, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
AnaptysBio, Inc. Upgrade
SELLAS Life Sciences Group, Inc. Upgrade